All News #Library
Others
Pyros Pharmaceuticals Launches VIGAFYDE, Ready-to-Use Vigabatrin Solution
03 Sep 2024 //
BUSINESSWIRE
Pyros Pharma Abstract Accepted For Poster At AES 2024 Annual Meeting
20 Aug 2024 //
BUSINESSWIRE
Pyros Pharmaceuticals Announces FDA Approval of VIGAFYDE™
18 Jun 2024 //
BIOSPACE
Pyros Pharma Announces FDA Approval Of VIGAFYDE™ Oral Solution
17 Jun 2024 //
BUSINESSWIRE
Pyros Announces Positive Outcome of the Procedure for Approval of VIGZIP
15 Feb 2024 //
BUSINESSWIRE
Pyros Pharmaceuticals’ Abstract Accepted for Poster Presentation
10 Oct 2023 //
BUSINESSWIRE

Market Place
Sourcing Support